Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-13 @ 7:12 AM
Study NCT ID:
NCT02456857
Status:
COMPLETED
Last Update Posted:
2024-02-13
First Post:
2015-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-27
First Submit QC Date:
None
Study First Post Date:
2015-05-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-12-20
Results First Submit QC Date:
None
Results First Post Date:
2024-02-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-17
Last Update Post Date:
2024-02-13
Last Update Post Date Type:
ACTUAL